3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 28340451 | The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide. | 2017 Apr | 1 |
| 2 | 28893623 | CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2. | 2017 Nov | 1 |
| 3 | 22822591 | Abiraterone. After prostate cancer treatment failure: 4-month survival advantage. | 2012 Jun | 1 |